Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2004 1
2005 1
2006 3
2007 6
2009 3
2010 6
2011 5
2012 5
2013 5
2014 2
2015 2
2016 4
2017 4
2018 7
2019 4
2020 5
2021 5
2022 9
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
Fornecker LM, Lazarovici J, Aurer I, Casasnovas RO, Gac AC, Bonnet C, Bouabdallah K, Feugier P, Specht L, Molina L, Touati M, Borel C, Stamatoullas A, Nicolas-Virelizier E, Pascal L, Lugtenburg P, Di Renzo N, Vander Borght T, Traverse-Glehen A, Dartigues P, Hutchings M, Versari A, Meignan M, Federico M, André M; LYSA-FIL-EORTC Intergroup. Fornecker LM, et al. Among authors: aurer i. J Clin Oncol. 2023 Jan 10;41(2):327-335. doi: 10.1200/JCO.21.01281. Epub 2022 Jul 22. J Clin Oncol. 2023. PMID: 35867960 Free article. Clinical Trial.
Author reply.
Basic-Kinda S, Karlak I, Durakovic N, Lubina ZI, Radman I, Dotlic S, Peric Z, Hude I, Aurer I. Basic-Kinda S, et al. Among authors: aurer i. Intern Med J. 2018 Jun;48(6):748-749. doi: 10.1111/imj.13822. Intern Med J. 2018. PMID: 29898265 No abstract available.
Unmet needs in the scientific approach to older patients with lymphoma.
Bron D, Aurer I, André MPE, Bonnet C, Caballero D, Falandry C, Kimby E, Soubeyran P, Zucca E, Bosly A, Coiffier B; European Lymphoma Institute (ELI) Group and the EHA SWG “Aging and Hematology”. Bron D, et al. Among authors: aurer i. Haematologica. 2017 Jun;102(6):972-975. doi: 10.3324/haematol.2017.167619. Haematologica. 2017. PMID: 28566341 Free PMC article. Review. No abstract available.
Tackling Mantle Cell Lymphoma in Europe.
Horgan D, Walewski J, Aurer I, Visco C, Giné E, Fetica B, Jerkeman M, Kozaric M, da Silva MG, Dreyling M. Horgan D, et al. Among authors: aurer i. Healthcare (Basel). 2022 Sep 3;10(9):1682. doi: 10.3390/healthcare10091682. Healthcare (Basel). 2022. PMID: 36141294 Free PMC article.
The EHA Research Roadmap: Malignant Lymphoid Diseases.
Dreyling M, André M, Gökbuget N, Tilly H, Jerkeman M, Gribben J, Ferreri A, Morel P, Stilgenbauer S, Fox C, Maria Ribera J, Zweegman S, Aurer I, Bödör C, Burkhardt B, Buske C, Dollores Caballero M, Campo E, Chapuy B, Davies A, de Leval L, Doorduijn J, Federico M, Gaulard P, Gay F, Ghia P, Grønbæk K, Goldschmidt H, Kersten MJ, Kiesewetter B, Landman-Parker J, Le Gouill S, Lenz G, Leppä S, Lopez-Guillermo A, Macintyre E, Mantega MVM, Moreau P, Moreno C, Nadel B, Okosun J, Owen R, Pospisilova S, Pott C, Robak T, Spina M, Stamatopoulos K, Stary J, Tarte K, Tedeschi A, Thieblemont C, Trappe RU, Trümper LH, Salles G. Dreyling M, et al. Among authors: aurer i. Hemasphere. 2022 May 19;6(6):e726. doi: 10.1097/HS9.0000000000000726. eCollection 2022 Jun. Hemasphere. 2022. PMID: 35620592 Free PMC article. No abstract available.
Precision medicine in diffuse large B-cell lymphoma: hitting the target.
Vermaat JS, Pals ST, Younes A, Dreyling M, Federico M, Aurer I, Radford J, Kersten MJ; EHA Lymphoma Group, a Scientific Working Group of the European Hematology Association. Vermaat JS, et al. Among authors: aurer i. Haematologica. 2015 Aug;100(8):989-93. doi: 10.3324/haematol.2015.128371. Haematologica. 2015. PMID: 26314080 Free PMC article. No abstract available.
75 results